Powerful Probiotic Formula: Each capsule of Datum Labs Akkermansia Muciniphila contains a potent blend of 1 billion live CFUs of Akkermansia muciniphila, a gram-negative bacterium known for its beneficial effects on gut health.

Guaranteed Live Probiotic: Akkermansia muciniphila is a gram-negative bacterium that grows under strict anaerobic conditions. Datum Labs employs a unique freeze-drying process to ensure the viability of the Akkermansia bacterium, delivering maximum potency and efficacy with every capsule.

Plant-Based, Acid-Resistant, DR Capsules: Our unique plant-based, acid-resistant, delayed-release capsules ensure that the Akkermansia strain reaches your gut microbiome intact, where it can thrive and support a healthy digestive system and gut flora.

Backed by Science: Studies show that Akkermansia muciniphila makes up to 4% of the intestinal bacteria in healthy individuals. It has been demonstrated to increase GLP-1 secretion**, emphasizing its importance for maintaining a balanced gut microbiome and a healthy weight.

Benefits of Datum Labs Akkermansia Muciniphila: Datum Labs Akkermansia Muciniphila supercharges GLP-1 production, enhances digestion, supports a balanced gut microbiome, and contributes to immunity and overall health.

High-Quality Manufacturing: Datum Labs Akkermansia Muciniphila is manufactured in the USA according to cGMP standards and is designated as GRAS (Generally Recognized As Safe). It is shelf-stable, vegan, and it is 100% non-GMO, soy-free, yeast-free, gluten-free, egg-free, and free of artificial colors/flavors & preservatives.

Ingredients You Can Trust: Datum Labs Akkermansia Muciniphila is made in the USA with premium chicory inulin, a prebiotic fiber that feeds the Akkermansia probiotic, promoting a balanced gut microbiome.

Citations

**Cani PD, Knauf C. A newly identified protein from Akkermansia muciniphila stimulates GLP-1 secretion. Cell Metab. 2021 Jun 1;33(6):1073-1075. doi: 10.1016/j.cmet.2021.05.004. PMID: 34077715.

Cani PD, Depommier C, Derrien M, Everard A, de Vos WM. Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms. Nat Rev Gastroenterol Hepatol. 2022 Oct;19(10):625-637. doi: 10.1038/s41575-022-00631-9. Epub 2022 May 31. Erratum in: Nat Rev Gastroenterol Hepatol. 2022 Jun 23;: PMID: 35641786.

Zhang T, Li Q, Cheng L, Buch H, Zhang F. Akkermansia muciniphila is a promising probiotic. Microb Biotechnol. 2019 Nov;12(6):1109-1125. doi: 10.1111/1751-7915.13410. Epub 2019 Apr 21. PMID: 31006995; PMCID: PMC6801136.

Hasani A, Ebrahimzadeh S, Hemmati F, Khabbaz A, Hasani A, Gholizadeh P. The role of Akkermansia muciniphila in obesity, diabetes and atherosclerosis. J Med Microbiol. 2021 Oct;70(10). doi: 10.1099/jmm.0.001435. PMID: 34623232.